china vanke co ltd -a
(000002:Shenzhen Stock Exchange)
|Age||Total Calculated Compensation||This person is connected to 8 board members in 1 different organizations across 4 different industries.|
See Board Relationships
Mr. Yin Wang serves as the Chief Financial Officer of Weikang Bio-Technology Group Company., the parent company of Tianfang (Guizhou) Pharmaceutical Co., Ltd. Mr. Wang served as Deputy Managing Director of China Resources (Holdings) Co., Ltd. He was a Deputy General Manager of China Resources (Holdings) Co. Ltd. since 2003. Mr. Wang served as Vice President of China Resources (Holdings) Co., Ltd. He joined China Resources National Corp. in 1984 and served as General ...
Vanke CenterPhone: 86 755 2560 6666
Shenzhen, Guangdong Province 518083
Fax: 86 755 2553 1696
Board Members Memberships*
University of San Francisco
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.